electroCore, Inc. Common Stock ECOR
Analyst Ratings
- Consensus
- Buy — 1 Buy · 0 Hold · 0 Sell (1 analysts)
- Avg. Price Target
- $18.00 (+57.1% upside)
Key Stats
- Today's Range
- $11.14 – $11.67
- 50-Day Range
- $5.63 – $11.93
- 52-Week Range
- $4.41 – $11.93
- Volume
- 50K shs
- Average Volume
- 89K shs
- Market Cap
- $102.60 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- -36.77
- Price / Sales
- 2.78
Short Interest
- Short Interest
- 0.22%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $36.97 million
- Net Income
- $-14,770,000
- Net Margin
- -39.96%
- Return on Equity
- 529.39%
- Debt-to-Equity
- -2.78
About electroCore, Inc. Common Stock
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Related Stocks
Compare head-to-head: ECOR vs MDT·ECOR vs AXGN·ECOR vs BLFS·ECOR vs CNMD
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.